Scholarlink

<p>Ischemic heart disease (IHD) remains the leading cause of disability and mortality around the world, urgently requiring precise, efficient, and safe therapeutic strategies. Natural products have proven effective in treating IHD. However, their clinical efficacy is limited by issues such as low bioavailability and poor targeting. Therefore, nanotechnology has emerged as a powerful solution to enhance the therapeutic value of natural products. This article systematically explores the integrated application of nanotechnology and natural products, focusing on their potential in treating IHD, including coronary atherosclerosis, myocardial infarction, reperfusion injury, and heart failure. Finally, the article discusses the challenges of translating natural product-based nanomedicines into clinical applications. This review aims to provide a comprehensive reference for the development of natural product-based nanomedicines for the treatment of IHD.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Therapeutic strategies for ischemic heart disease with natural product-based nanomedicines

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月11日

查看全文
  • Pei-rong Qu,
  • Fan Jia,
  • Xin Liu,
  • Yue-qi Wang,
  • Chang-jian Li,
  • Jie-ming Lu,
  • Hao Guo,
  • Long-xin Qian,
  • Hao-wei Guan,
  • Hua Qu,
  • Chang-geng Fu,
  • Lin-zi Long

摘要

Ischemic heart disease (IHD) remains the leading cause of disability and mortality around the world, urgently requiring precise, efficient, and safe therapeutic strategies. Natural products have proven effective in treating IHD. However, their clinical efficacy is limited by issues such as low bioavailability and poor targeting. Therefore, nanotechnology has emerged as a powerful solution to enhance the therapeutic value of natural products. This article systematically explores the integrated application of nanotechnology and natural products, focusing on their potential in treating IHD, including coronary atherosclerosis, myocardial infarction, reperfusion injury, and heart failure. Finally, the article discusses the challenges of translating natural product-based nanomedicines into clinical applications. This review aims to provide a comprehensive reference for the development of natural product-based nanomedicines for the treatment of IHD.

Graphical abstract